BioNTech (Germany)

BioNTech (Germany)

BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioNTech (Germany), Germany, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

70%


Total
Publications

783


Total Open
Publications

550


Total
Citations

49K


Open Access
Percentage

70%


Total
Publications

783


Total Open
Publications

550


Total
Citations

49K

Wikipedia

Website

download

Breakdown

16% 40% 14% 30%

Publisher Open

16%

Both

40%

Other Platform Open

14%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

51%OA Journal

OA Journal 51%

223

Hybrid 25%

109

No Guarantees 24%

105

Other Platform Open

Domain 69%

289

Institution 51%

214

Preprint 18%

75

Other Internet 8%

34

Public 1%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
295
doaj.org OAI-PMH Repository
Institution
156
bioRxiv
Preprint
42
DOI
Other Internet
32
Europe PMC
Domain
14
medRxiv
Preprint
13
Research Square
Preprint
11
Royal Netherlands Academy of Arts and Sciences
Institution
8
Leiden University
Institution
8
Deutsches Elektronen-Synchrotron DESY
Institution
7
1 / 8

Data updated 13 July 2026

Share

Share

Share